News tagged with bevacizumab
AMD drug and IOP; getting good eyeglasses to those in need
Oct 26, 2009 |
not rated yet |
0
A first-time finding of intraocular pressure increases in patients with no personal or family history of glaucoma following anti-VEGF treatment for wet age-related macular degeneration (AMD), and a report on a simple, low-cost ...
Cancer drug is no different in effectiveness as gold standard treatment for macular degeneration
Oct 09, 2009 |
not rated yet |
0
Investigators from Boston University School of Medicine (BUSM) and the VA Boston Healthcare System have shown, at 6 months in a small group of patients, that there is no difference in efficacy between Bevacizumab (Avastin) ...
New treatments offer better survival and fresh challenges in colorectal cancer
Aug 21, 2009 |
not rated yet |
0
Colorectal cancer (CRC) is the second leading cause of cancer-related death in the Western world. Fortunately physicians today have an abundance of drug therapies available to improve survival length for more advanced cancer ...
Costly cancer drugs are worth it, study finds
Aug 14, 2009 |
2.5 / 5 (2) |
2
(PhysOrg.com) -- The cost for chemotherapy medications to treat colorectal cancer for six months has jumped 2,600 percent from 1993 to 2005. But such rising costs are worth the price, asserts a new report from Cornell, when ...
Anti-growth factor drugs raise hope and concern for treatment of children's eye diseases
Aug 03, 2009 |
not rated yet |
0
A new class of antibody drugs may provide a powerful new tool for the treatment of eye diseases in children, but specialists need to be alert for the possibility of serious side effects, according to an editorial in the August ...
Cancer treatment controls macular edema related to diabetes and to cataract surgery
Jul 31, 2009 |
5 / 5 (1) |
0
This month's Ophthalmology, the journal of the American Academy of Ophthalmology, reports on use of bevacizumab (Avastin), to benefit diabetic patients with macular edema as well as people who develop cystoid macular edema ...
Study shows drug combination improves outcome for advanced non-small cell lung cancer
May 31, 2009 |
5 / 5 (1) |
0
A new, international study found that the combination of two drugs delays disease progression for patients with advanced non-small cell lung cancer (NSCLC). Results from the Phase III "ATLAS" trial were presented today by ...
MicroRNA-based Diagnostic Identifies Squamous Lung Cancer with 96% Sensitivity
Mar 10, 2009 |
4 / 5 (1) |
0
A new study shows for the first time that a microRNA-based diagnostic test can objectively identify squamous lung cancer with 96% sensitivity, according to Harvey Pass, M.D. of the NYU Cancer Institute at NYU Langone Medical ...
Doctors' resources for off-label prescribing may be incomplete, unclear
Feb 16, 2009 |
not rated yet |
0
The resources doctors use to get important information about indications and reimbursement for use of cancer drugs off-label may be out-of-date and incomplete, according to a study led by researchers in the Duke Comprehensive ...
